Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness

Pediatr Infect Dis J. 2004 Sep;23(9):881-2. doi: 10.1097/01.inf.0000136857.74561.3c.

Abstract

Pandoraea is a recently classified genus primarily isolated from the sputum of cystic fibrosis patients, but its pathogenic potential is unknown. We describe a case of Pandoraea bacteremia in a 16-year-old cystic fibrosis patient associated with clinical disease, suggesting that this organism should be considered a true pathogen in susceptible patients.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / pharmacology
  • Bacteremia / complications
  • Bacteremia / diagnosis*
  • Bacteremia / drug therapy
  • Betaproteobacteria / isolation & purification*
  • Burkholderia Infections / complications
  • Burkholderia Infections / diagnosis*
  • Burkholderia Infections / drug therapy
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / diagnosis*
  • Drug Therapy, Combination / therapeutic use
  • Follow-Up Studies
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / microbiology*
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents